Searched for
INDIA DRUGS
The young people we never seeRecent research underscores the importance of social interaction in mitigating adolescent substance abuse risks. Key elements, such as a se...- First terrorism, then Naxalism, now drugs: By 2029, Amit Shah sets hard deadline to wipe out India’s narcotics menace & Punjab crisisUnion home minister Amit Shah has set December 31, 2029, as the target to make India drug-free, saying the Centre will focus on tackling th...
- AAP chief Aravind Kejriwal questions HM Amit Shah over drug menace in BJP-ruled statesArvind Kejriwal criticised Amit Shah for the ongoing drug issues in BJP-ruled states like Bihar and Gujarat. Shah had expressed his sadness...
- FDA recalls 17 toothpaste varieties nationwide, affecting over 4 million tubes, including children's flavors and whitening productsOver 4 million tubes of toothpaste have been recalled by the FDA due to significant violations of Good Manufacturing Practices, predominant...
- Amit Shah hails security personnel for violence-free Bengal pollsUnion home minister Amit Shah confirmed that peace has been established in Kashmir, the Northeast, and Naxal-affected areas. He highlighted...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
- Tiger Shroff firing case: Haryana Police identified accused, assisted Mumbai Police, says DGP Ajay SinghalHaryana Police assisted Mumbai Police in investigating a recent firing incident involving actor Tiger Shroff's car. The actor escaped unhar...
- Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
- Dr Reddy's gets DCGI nod for Zytorvi in advanced esophageal cancerDr Reddy's Laboratories has received approval for Zytorvi, an immunotherapy targeting advanced esophageal squamous cell carcinoma. This new...
- Sweet sellers face heat over shelf life rules ahead of DiwaliWatchdog agencies in states such as Uttar Pradesh and Uttarakhand are among those that have made this mandatory. The directive aims to help...
- Don't stunt the stent, med devices sectorThree coronary stent models from Meril Life Sciences were withdrawn from the Sri Lankan market due to performance issues. The National Medi...
- NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. ...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- India's internal security landscape has changed irrevocably: Union Home SecretaryUnion Home Secretary Govind Mohan on Saturday said India’s internal security challenges have changed, with Naxalism largely ended, insurgen...
- MHA seeks detailed report from Punjab on Gurdaspur incident which left one deadThe Union Ministry of Home Affairs has requested a detailed report from Punjab regarding recent violent incidents. One incident resulted in...
- Drug menace in Punjab at 'alarming level', state needs govt that can keep people safe: Nitin NabinBJP president Nitin Nabin targeted the AAP government in Punjab and said the drug crisis has reached an "alarming level." He emphasised the...
- Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launchBiocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to laun...
- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
- Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growthKiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need f...
- SC asks govt to broaden inflated pricing review beyond oncologyThe Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...
Load More
